UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?

Brownlee, WJ; (2020) COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual? Multiple Sclerosis Journal , 26 (10) p. 1267. 10.1177/1352458520948211. Green open access

[thumbnail of COVID-19 and high-efficacy multiple sclerosis therapies Time for business as usual.pdf]
Preview
 Text
COVID-19 and high-efficacy multiple sclerosis therapies Time for business as usual.pdf - Published Version
Download (436kB) | Preview
Type: Article
Title: COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?
Open access status: An open access version is available from UCL Discovery
DOI: 10.1177/1352458520948211
Publisher version: https://doi.org/10.1177%2F1352458520948211
Language: English
Additional information: © 2021 by SAGE Publications. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/).
Keywords: COVID-19, multiple sclerosis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10126617
Downloads since deposit
32Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item